Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignancies
R M Lush, W D Figg, J M Pluda, et al.
The Cancer Journal From Scientific American
|
May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma
G Y Ma, D L Bartlett, E Reed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
A M Senderowicz, D Headlee, S F Stinson, et al.
Journal of Clinical Pharmacology
|
April 10, 1999
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis
H K Cho, R M Lush, D L Bartlett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms
E A Sausville, S G Arbuck, R Messmann, et al.
Blood
|
August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma
M J Stone, E A Sausville, J W Fay, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
A phase I study of pentosan polysulfate sodium in patients with advanced malignancies
R M Lush, W D Figg, J M Pluda, et al.
The Cancer Journal From Scientific American
|
May 1, 1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma
G Y Ma, D L Bartlett, E Reed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
A M Senderowicz, D Headlee, S F Stinson, et al.
Journal of Clinical Pharmacology
|
April 10, 1999
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis
H K Cho, R M Lush, D L Bartlett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms
E A Sausville, S G Arbuck, R Messmann, et al.
Blood
|
August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma
M J Stone, E A Sausville, J W Fay, et al.
Page
of 3